65,437 trials
Hypertension
Primary: Mean Change From Baseline in Trough Sitting Diastolic Blood Pressure (SiDBP) at Week 12 — -2.0; -5.8; -6.3; -8.0 mm Hg
Bipolar Disorder I or II
Primary: Mean Changes From Baseline to 6 Week and 24 Week Endpoints in the Multidimensional Assessment of THYmic States Scale (MATHYS) Total Score — 140.55; 136.52; 116.74; 76.88…
Type 1 Diabetes Mellitus · Type 2 Diabetes Mellitus
Primary: Incidence of Patient-Ascertained Severe Hypoglycemia (PASH) During the Adjustment Period — 4.8; 2.8 Incidence (%)
Crohn Disease
Primary: Percentage of Participants With Corticosteriod-free Clinical Remission — 30.0; 44.4; 56.8 percentage of participants — p=<0.001
AIDS
Primary: Standing and Supine Systolic and Diastolic Blood Pressure (BP) — 118.36; 119.47; 68.06; 69.99 mm Hg
Benign Prostatic Hyperplasia
Primary: Change From Baseline to 12 Week Endpoint in Detrusor Pressure at Peak Urinary Flow Rate (PdetQmax) — 54.83; 56.87; 1.92; -2.95 centimeters of water (cm H20) — p=0.068
Myopia
Primary: Distance Visual Acuity — 0.03460; 0.02931 logMar
Cardiovascular Disease · Hypertension · Hyperlipidemia
Primary: Systolic Blood Pressure — 121.7; 129.7 mm Hg
Breast Neoplasms · Breast Cancer
Primary: Number of Subjects With Response (Complete or Partial) — 0; 1; 20; 31 participants
Gingivitis
Primary: Gingivitis Index — 1.00; 1.27 Units on a scale — p=0.05
Hypertension · Metabolic Disorder
Primary: Change in Hemoglobin A1c Between 52 Weeks and Baseline — 0.04 Percent — p=0.999
Sepsis
Primary: Antibiotic Treatment for More Than 72 Hours — 33; 55 participants — p=0.002
Anxiety Disorders
Primary: Change in the Hamilton Rating Scale for Anxiety (HAM-A) Total Score — -14.97; -7.21 units on scale
Dental Plaque
Primary: Plaque Index — 0.91; 0.84; 1.77 Units on a scale — p=0.05
Hypoxia · Altitude · Heart Failure
Primary: Peak Exercise Oxygen Consumption — 33.9; 37.6; 38.0; 33.9 ml/Kg/min — p=0.01